Risk Factors and Prevention Strategies for Childhood Obesity Among Male Elementary Schoolchildren Aged 6–10 Years

Main Article Content

Dr. Anil Kumar Muthineni

Abstract

This study investigates the prevalence and contributing factors of overweight and obesity among male elementary schoolchildren aged 6 to 10 years. Conducted using a cross-sectional design from May 2021 to October 2024, the research analyzed data from 662 students using chi-squared and logistic regression analyses. The results revealed that 20.2% of the children were overweight, and 16.8% were obese. Significant risk factors identified included having obese siblings, an unemployed father, living in a large household, and poor dental health. Additionally, increasing age and higher educational levels were associated with a greater risk of obesity. Children who engaged in frequent dieting practices were more likely to experience weight gain compared to those who did not. The study emphasizes the importance of parental involvement, as parental obesity emerged as a strong predictor of childhood obesity. To address these issues, the research advocates for comprehensive health education programs, regular pediatric screenings, and culturally relevant community interventions tailored to the Arab world. Schools should play a pivotal role in promoting healthy eating and physical activity, while the government should implement targeted policies to address socioeconomic disparities. Collaboration among families, educators, healthcare providers, and policymakers is crucial for reducing childhood obesity rates. Long-term, culturally sensitive efforts are vital for promoting health equity and reducing the public health and economic burdens associated with obesity in Kuwait and similar contexts.

Article Details

How to Cite
Dr. Anil Kumar Muthineni. (2022). Risk Factors and Prevention Strategies for Childhood Obesity Among Male Elementary Schoolchildren Aged 6–10 Years. Journal for ReAttach Therapy and Developmental Diversities, 5(2), 658–663. Retrieved from https://mail.jrtdd.com/index.php/journal/article/view/3639
Section
Articles
Author Biography

Dr. Anil Kumar Muthineni

Associate Professor, Department of General Medicine, Sri Lakshmi Narayana Institute of Medical Sciences & Hospital, Osudu, Puducherry - 605502

References

Heller, W., and Pugh, T. L. Steric stabilization of collidal solutions by adsorption of flexible macromolecules. J. Polym. Sci. 1960; 203–217.

Jaeschke, H., Werner, C., and Wendel, A. Disposition and Hepatoprotec- tion by phosphatidyl Choline liposomes in mouse liver. Chem. Biol. Interact. 64: 1987; 127–137.

Karison, P. Kurzes Lehrbuch der Biochemic fu¨r Mediziner and Naturwis- senschaftler. Thieme Verlag. 1984; 134–141.

Miguez, M. P., Anundi, I., Sainz-Pardo, L. A., and Lindros, K. O. Hepatoprotective mechanism of Silymarin: No evidence for involvement of Cytochrome P450 2E1. Chem. Biol. Interact. 91: 1994; 51–63.

Miyata, I., Miyamoto, H., and Yonese, M. Effect of chain lengths of n-Alcohol on the formation of Single-phase microemulsions in n-Heptane/n-Alcohol/sodium Dodecyl Sulfate/water systems. Chem. Pharm. Bull. 1996; 1049–1055.

Mizushima, Y., Hamano, T., and Yokoyama, K. Use of lipid emulsions as a novel carrier for consticosteroids. J. Pharm. Pharmacol. 34: 1982; 49–50.

Mizushima, Y., Wada, Y., Etoh, Y., and Watanabe, K. Antiinflammatory effect of indomethacin ester incorporated in lipid microsphere. J. Pharm. Pharmacol. 35: 1983; 398–399.

Moreno, M. A., Frutos, P., and Ballesteros, M. P. Lyophilized lecithin based oil-in-water microemulsions as new and low toxic delivery system for Amphotericin B. Pharm. Res. 18: 2001; 344–351.

Wellington, K., and Jarvis, B. Silymarin: A review of its clinical properties in the management of hepatic disorders. Bio. Drugs. 15: 2001; 465–489.

Yamaguchi, T. Lipid microspheres for drug delivery from the pharmaceu- tical viewpoint. Crit. Rev. Ther. Drug Carrier Sys. 11: 1994; 215–229

American Diabetes Association, et al. Diagnosis and classification of diabetes. Diabetes Care, 34(Suppl 1), 2011, S62–S69.

Tuomilehto, Jaakko, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344(18), 2001, 1343–1350.

Davies, Peter H., et al. How to diagnose diabetes? Practicalities and comments on the WHO provisional recommendation in favor of HbA1c. British Journal of Diabetes & Vascular Disease, 10(6), 2010, 261–264.

Wiwanitkit, Viroj, et al. Laboratory investigation for diabetes mellitus: Practical concerns. The Open Diabetes Journal, 2, 2009, 32–34.

Bennett, Philip N., et al. Diabetes mellitus, insulin, oral antidiabetic agents, and obesity. Clinical Pharmacology, 11th ed., Churchill Livingstone, 2012, 572–586.

Patki, V. P., et al. Progress made in noninvasive insulin delivery. Indian Journal of Pharmacology, 28, 1996, 143–151.

Harvey, Richard A., et al. Insulin and oral hypoglycemic drugs. Lippincott’s Illustrated Reviews: Pharmacology, 6th ed., Lippincott Williams & Wilkins, 2015, 355–380.

Russell-Jones, David, et al. Current developments in the treatment of diabetes: The incretin therapies. British Journal of Diabetes & Vascular Disease, 10(1), 2010, 21–30.

Fowler, Michael J., et al. Diabetes treatment: Oral agents. Clinical Diabetes, 28(3), 2010, 132–136.

Chakraborti, Chitta K., et al. The potential role of vidagliptin in the management and prevention of type 2 diabetes mellitus. Indian Journal of Pharmacology, 40(1), 2008, 10–14.